Product Information

PREGABALIN 300 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0658 per EA under NDC 67877046990. Its NADAC has been published 356 times since Sep 4, 2019.

PREGABALIN 300 MG CAPSULE

Pregabalin
$0.0658per EA
DEA Schedule CV

Strength

300 mg/1

NDC

67877046990

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA207799

On Market Since

7/21/2019

Price Statistics

The NADAC for PREGABALIN 300 MG CAPSULE has been published 356 times since Sep 4, 2019, and over the history we have for it it has declined 72.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0658 per EA
All-time high$0.2379 (Sep 11, 2019)
All-time low$0.0628 (Nov 20, 2024)
52-week high$0.0803
52-week low$0.0652
Median price$0.1020
Average price$0.1156
Largest weekly change+30.8% (Aug 21, 2024)
Weeks tracked356
Tracking sinceSep 4, 2019

Price History

1W

0.0%

1M

+0.9%

3M

+0.8%

6M

-5.0%

1Y

-18.0%

3Y

-34.4%

5Y

-48.1%

All

-72.3%

Generic Alternatives

The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PREGABALIN 300 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 300 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $0.0658 per EA (NDC 67877046990), effective Jun 24, 2026.

How has the price of PREGABALIN 300 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PREGABALIN 300 MG CAPSULE has declined 72.3%. It has been tracked across 356 weekly CMS publications since Sep 4, 2019.

What are the highest and lowest recorded NADAC prices for PREGABALIN 300 MG CAPSULE?

Since Sep 4, 2019, the NADAC for PREGABALIN 300 MG CAPSULE has ranged from a low of $0.0628 (Nov 20, 2024) to a high of $0.2379 (Sep 11, 2019), with a median of $0.1020 per EA.

Are there cheaper alternatives to PREGABALIN 300 MG CAPSULE?

10 NADAC-published products share the same active ingredient, strength, and dosage form as PREGABALIN 300 MG CAPSULE, but none are currently priced below it.

Who manufactures PREGABALIN 300 MG CAPSULE?

PREGABALIN 300 MG CAPSULE (NDC 67877046990) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.